×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Hagan Joseph P

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Executive OfficerJan 18, 2024Sale$1.1914,58017,35957,112Jan 18, 2024, 08:22 PM
AUPHAurinia Pharmaceuticals Inc.Hagan Joseph PDirectorMay 19, 2023Sale$10.582722,87811,961May 23, 2023, 05:18 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOJan 26, 2022Buy$0.22100,00021,520417,006Jan 26, 2022, 04:13 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOFeb 16, 2021Sale$1.724,1447,128244,628Apr 16, 2021, 04:11 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOFeb 16, 2021Sale$1.724,1447,128485,756Feb 17, 2021, 05:23 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEODec 04, 2020Option Exercise$0.6339,68025,002225,674Dec 07, 2020, 04:22 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEONov 16, 2020Sale$0.526,0943,176215,994Nov 18, 2020, 04:09 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOAug 14, 2020Sale$0.604,2452,568222,088Aug 17, 2020, 08:22 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOMay 15, 2020Sale$0.634,4262,774226,333May 18, 2020, 04:28 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOFeb 18, 2020Sale$0.834,3243,591230,759Feb 19, 2020, 06:09 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOJan 02, 2020Sale$0.978,3458,067235,083Jan 03, 2020, 04:07 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEONov 14, 2019Sale$0.645,8383,736243,428Nov 15, 2019, 05:36 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOct 01, 2019Sale$0.688,7435,969249,266Oct 02, 2019, 06:17 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOAug 15, 2019Sale$0.554,3752,409258,009Aug 16, 2019, 04:17 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOJul 01, 2019Sale$1.315,7837,584262,384Jul 02, 2019, 05:42 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOMay 07, 2019Option Exercise$1.0833,19435,85064,542May 21, 2019, 04:42 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOMay 16, 2019Sale$1.2239,35247,966268,167May 16, 2019, 05:25 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOMay 07, 2019Buy$1.0833,19435,85064,542May 08, 2019, 05:15 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOApr 01, 2019Sale$0.985,8425,73131,348Apr 03, 2019, 04:31 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOFeb 05, 2019Option Exercise$0.9565,00061,75084,148Feb 06, 2019, 04:51 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOJul 25, 2017Buy$0.91219,780200,000241,297Jul 25, 2017, 06:08 PM
RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Operating OfficerMar 03, 2016Buy$7.1910,00071,90010,000Mar 07, 2016, 05:20 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PSr. VP, Corporate DevelopmentSep 15, 2014Buy$4.695,00023,45013,026Sep 15, 2014, 03:11 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerNov 29, 2013Option Exercise$5.343,98021,2533,980Feb 11, 2014, 07:33 AM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerJul 31, 2013Option Exercise$4.7324,000113,52012,000Aug 02, 2013, 07:34 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerJul 26, 2013Option Exercise$4.5320,00090,60010,000Jul 29, 2013, 07:49 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerMay 28, 2013Option Exercise$4.3356,000242,48028,000May 30, 2013, 05:38 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerJul 13, 2012Sale$4.2160,000252,80030,000Jul 13, 2012, 08:13 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerJun 27, 2012Option Exercise$3.46140,000484,20070,000Jun 29, 2012, 06:58 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerJun 28, 2012Sale$3.7852,000196,56026,000Jun 29, 2012, 06:58 PM
OREXOrexigen Therapeutics, Inc.Hagan Joseph PChief Business OfficerJun 29, 2012Sale$3.9824,00095,52012,000Jun 29, 2012, 06:58 PM